{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:15:24Z","timestamp":1788243324781,"version":"build-2803163510"},"reference-count":199,"publisher":"Jaypee Brothers Medical Publishing","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.59556\/japi.72.0620","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T09:12:08Z","timestamp":1752225128000},"page":"e1-e25","source":"Crossref","is-referenced-by-count":13,"title":["Management of Hypertension in Patients with Type 2 Diabetes Mellitus: Indian Guideline 2024 by Association of Physicians of India and Indian College of Physicians"],"prefix":"10.59556","volume":"72","author":[{"given":"Gurpreet Singh","family":"Wander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanta K","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotirmoy","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Sahay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangesh","family":"Tiwaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sekhar","family":"Chakrabarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devendra Prasad","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L Sreenivasa","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujoy","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shambo S","family":"Samajdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv","family":"Maheswari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2914","reference":[{"issue":"(3):","key":"key20250711091203_B1","doi-asserted-by":"crossref","first-page":"363\u2013","DOI":"10.1001\/jamainternmed.2017.8094","article-title":"Diabetes and hypertension in India: a nationally representative study of 1.3 million adults.","volume":"178","author":"Geldsetzer","year":"2018;","journal-title":"JAMA Intern Med"},{"issue":"(7):","key":"key20250711091203_B2","doi-asserted-by":"crossref","first-page":"474\u2013","DOI":"10.1016\/S2213-8587(23)00119-5","article-title":"Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17).","volume":"11","author":"Anjana","year":"2023;","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"(5):","key":"key20250711091203_B3","doi-asserted-by":"crossref","first-page":"575\u2013","DOI":"10.1016\/j.cjca.2017.12.005","article-title":"Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms.","volume":"34","author":"Petrie","year":"2018;","journal-title":"Can J Cardiol"},{"issue":"(1).","key":"key20250711091203_B4","article-title":"Evolution of blood pressure control identification in lieu of post-surgery diabetic patients: a review.","volume":"6","author":"Ahath","year":"2018;","journal-title":"Health Inf Sci Syst"},{"issue":"(4):","key":"key20250711091203_B5","doi-asserted-by":"crossref","first-page":"576\u2013","DOI":"10.1007\/s13410-022-01143-7","article-title":"RSSDI Guidelines for the management of hypertension in patients with diabetes mellitus.","volume":"42","author":"Kumar","year":"2022;","journal-title":"Int J Diabetes Dev Ctries"},{"key":"key20250711091203_B6","doi-asserted-by":"crossref","first-page":"18014.","DOI":"10.1038\/nrdp.2018.14","article-title":"Hypertension.","volume":"4:","author":"Oparil","year":"2018;","journal-title":"Nat Rev Dis Primer"},{"issue":"(6):","key":"key20250711091203_B7","doi-asserted-by":"crossref","first-page":"1334\u2013","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension Global Hypertension Practice Guidelines.","volume":"75","author":"Unger","year":"2020;","journal-title":"Hypertension"},{"issue":"(6):","key":"key20250711091203_B8","first-page":"e13\u2013","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines.","volume":"71","author":"Whelton","year":"2018;","journal-title":"Hypertension"},{"issue":"(5):","key":"key20250711091203_B9","doi-asserted-by":"crossref","first-page":"507\u2013","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).","volume":"311","author":"James","year":"2014;","journal-title":"JAMA"},{"issue":"(17):","key":"key20250711091203_B10","first-page":"1575\u2013","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus.","volume":"362","author":"Cushman","year":"2010;","journal-title":"N Engl J Med"},{"issue":"(22):","key":"key20250711091203_B11","first-page":"2103\u2013","article-title":"A randomized trial of intensive versus standard blood-pressure control.","volume":"373","author":"Wright","year":"2015;","journal-title":"N Engl J Med"},{"issue":"(10017):","key":"key20250711091203_B12","doi-asserted-by":"crossref","first-page":"435\u2013","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.","volume":"387","author":"Xie","year":"2016;","journal-title":"Lancet Lond Engl"},{"issue":"(6):","key":"key20250711091203_B13","doi-asserted-by":"crossref","first-page":"603\u2013","DOI":"10.1001\/jama.2014.18574","article-title":"Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.","volume":"313","author":"Emdin","year":"2015;","journal-title":"JAMA"},{"issue":"(7):","key":"key20250711091203_B14","doi-asserted-by":"crossref","first-page":"1281\u2013","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).","volume":"31","author":"Mancia","year":"2013;","journal-title":"J Hypertens"},{"key":"key20250711091203_B15","article-title":"| Diabetes Care |"},{"issue":"(1):","key":"key20250711091203_B16","doi-asserted-by":"crossref","first-page":"14\u2013","DOI":"10.1111\/jch.12237","article-title":"Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension.","volume":"16","author":"Weber","year":"2014;","journal-title":"J Clin Hypertens Greenwich Conn"},{"key":"key20250711091203_B17","article-title":"ESC\/ESH Guidelines for the management of arterial hypertension.","author":"Mancia","year":"2018"},{"key":"key20250711091203_B18"},{"issue":"(12):","key":"key20250711091203_B19","doi-asserted-by":"crossref","first-page":"1874\u2013","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).","volume":"41","author":"Mancia","year":"2023;","journal-title":"J Hypertens"},{"issue":"(Suppl 1):","key":"key20250711091203_B20","first-page":"S179\u2013","article-title":"10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes\u20142024.","volume":"47","year":"2023;","journal-title":"Diabetes Care"},{"issue":"(6):","key":"key20250711091203_B21","doi-asserted-by":"crossref","first-page":"389\u2013","DOI":"10.1038\/s41440-018-0034-4","article-title":"Hypertension with diabetes mellitus: physiology and pathology.","volume":"41","author":"Ohishi","year":"2018;","journal-title":"Hypertens Res"},{"issue":"(11):","key":"key20250711091203_B22","first-page":"1256\u2013","article-title":"Hypertension management in diabetic patients.","volume":"15","author":"Anwer","year":"2011;","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"(1):","key":"key20250711091203_B23","doi-asserted-by":"crossref","first-page":"134\u2013","DOI":"10.2337\/diacare.25.1.134","article-title":"The treatment of hypertension in adult patients with diabetes.","volume":"25","author":"Arauz-Pacheco","year":"2002;","journal-title":"Diabetes Care"},{"issue":"(2):","key":"key20250711091203_B24","doi-asserted-by":"crossref","first-page":"160\u2013","DOI":"10.1007\/s11883-012-0227-2","article-title":"Diabetes and hypertension: is there a common metabolic pathway?","volume":"14","author":"Cheung","year":"2012;","journal-title":"Curr Atheroscler Rep"},{"issue":"(5):","key":"key20250711091203_B25","doi-asserted-by":"crossref","first-page":"1197\u2013","DOI":"10.1161\/HYPERTENSIONAHA.121.17981","article-title":"Hypertension in diabetes: an update of basic mechanisms and clinical disease.","volume":"78","author":"Jia","year":"2021;","journal-title":"Hypertension"},{"issue":"(1):","key":"key20250711091203_B26","doi-asserted-by":"crossref","first-page":"139\u2013","DOI":"10.1038\/ki.1993.224","article-title":"Role of hyperglycemia and insulin resistance in determining sodium retention in non-insulin-dependent diabetes.","volume":"44","author":"Nosadini","year":"1993;","journal-title":"Kidney Int"},{"issue":"(16):","key":"key20250711091203_B27","doi-asserted-by":"crossref","first-page":"2085\u2013","DOI":"10.1161\/01.CIR.0000033824.02722.F7","article-title":"Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?","volume":"106","author":"Cruickshank","year":"2002;","journal-title":"Circulation"},{"issue":"(1):","key":"key20250711091203_B28","doi-asserted-by":"crossref","first-page":"12.","DOI":"10.1186\/1758-5996-6-12","article-title":"Link between insulin resistance and hypertension: what is the evidence from evolutionary biology?","volume":"6","author":"Zhou","year":"2014;","journal-title":"Diabetol Metab Syndr"},{"issue":"(3).","key":"key20250711091203_B29","article-title":"Association of insulin resistance and blood pressure in newly diagnosed patients of essential hypertension: a cross-sectional study.","volume":"20","author":"Gupta","year":"2019;","journal-title":"JIACM"},{"issue":"(2):","key":"key20250711091203_B30","first-page":"152.","article-title":"Anthropometric measures in risk prediction for type 2 diabetes mellitus?\u2014a cross-sectional study in regular athletes.","volume":"10","author":"Samajdar","year":"2021;","journal-title":"Int J Health Allied Sci"},{"issue":"(4):","key":"key20250711091203_B31","doi-asserted-by":"crossref","first-page":"224\u2013","DOI":"10.1111\/j.1751-7176.2011.00449.x","article-title":"Renin-angiotensin-aldosterone system in diabetes and hypertension.","volume":"13","author":"Hsueh","year":"2011;","journal-title":"J Clin Hypertens"},{"issue":"(11):","key":"key20250711091203_B32","first-page":"51\u2013","article-title":"The association of essential hypertension and diabetes.","volume":"15","author":"Ferrannini","year":"1989;","journal-title":"Compr Ther"},{"issue":"(2):","key":"key20250711091203_B33","doi-asserted-by":"crossref","first-page":"142.","DOI":"10.22159\/ijpps.2018v10i2.23891","article-title":"Prevalence and risk factors of essential hypertension and new onset of diabetes in essential hypertension in rural population of Haryana.","volume":"10","author":"Jhawat","year":"2018;","journal-title":"Int J Pharm Pharm Sci"},{"issue":"(7):","key":"key20250711091203_B34","doi-asserted-by":"crossref","first-page":"407\u2013","DOI":"10.1007\/BF00404089","article-title":"Prevalence of hypertension in type 1(insulin-dependent) diabetes mellitus.","volume":"33","author":"N\u00f8rgaard","year":"1990;","journal-title":"Diabetologia"},{"issue":"(1):","key":"key20250711091203_B35","doi-asserted-by":"crossref","first-page":"17\u2013","DOI":"10.1007\/s00125-004-1599-9","article-title":"An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study.","volume":"48","author":"Wu","year":"2005;","journal-title":"Diabetologia"},{"issue":"(12):","key":"key20250711091203_B36","doi-asserted-by":"crossref","first-page":"1251\u2013","DOI":"10.1016\/j.amjmed.2016.08.032","article-title":"Isolated systolic hypertension: an update after SPRINT.","volume":"129","author":"Bavishi","year":"2016;","journal-title":"Am J Med"},{"issue":"(8):","key":"key20250711091203_B37","doi-asserted-by":"crossref","first-page":"577\u2013","DOI":"10.1136\/heartjnl-2012-302029","article-title":"Blood pressure and diabetes: vicious twins.","volume":"99","author":"Chokshi","year":"2013;","journal-title":"Heart"},{"issue":"(2):","key":"key20250711091203_B38","doi-asserted-by":"crossref","first-page":"245\u2013","DOI":"10.18231\/j.pjms.2021.051","article-title":"Clinical profile of isolated systolic hypertension in elderly.","volume":"11","author":"Samal","year":"2021;","journal-title":"Panacea J Med Sci"},{"issue":"(23):","key":"key20250711091203_B39","doi-asserted-by":"crossref","first-page":"456.","DOI":"10.21037\/atm.2017.09.24","article-title":"Masked hypertension.","volume":"5","author":"Aronow","year":"2017;","journal-title":"Ann Transl Med"},{"issue":"(1):","key":"key20250711091203_B40","doi-asserted-by":"crossref","first-page":"50\u2013","DOI":"10.1080\/08037051.2022.2061415","article-title":"Utility of ambulatory blood pressure monitoring in detection of masked hypertension and risk of hypertension mediated organ damage in normotensive patients with type 2 diabetes mellitus.","volume":"31","author":"Gupta","year":"2022;","journal-title":"Blood Press"},{"issue":"(8):","key":"key20250711091203_B41","doi-asserted-by":"crossref","first-page":"601\u2013","DOI":"10.1111\/j.1524-6175.2007.06610.x","article-title":"Masked hypertension in diabetes mellitus: a potential risk.","volume":"9","author":"Eguchi","year":"2007;","journal-title":"J Clin Hypertens"},{"issue":"(10):","key":"key20250711091203_B42","doi-asserted-by":"crossref","first-page":"1079\u2013","DOI":"10.1016\/j.amjhyper.2007.06.005","article-title":"Masked hypertension in type 2 diabetes mellitus. Relationship with left-ventricular structure and function.","volume":"20","author":"Marchesi","year":"2007;","journal-title":"Am J Hypertens"},{"issue":"(1):","key":"key20250711091203_B43","doi-asserted-by":"crossref","first-page":"55\u2013","DOI":"10.4103\/ijem.ijem_226_21","article-title":"Hypertensive phenotypes and pattern of ambulatory blood pressure in patients of diabetes mellitus of Kashmir Valley.","volume":"26","author":"Bhat","year":"2022;","journal-title":"Indian J Endocrinol Metab"},{"issue":"(5):","key":"key20250711091203_B44","doi-asserted-by":"crossref","first-page":"964\u2013","DOI":"10.1161\/HYPERTENSIONAHA.111.00289","article-title":"Masked hypertension in diabetes mellitus.","volume":"61","author":"Franklin","year":"2013;","journal-title":"Hypertension"},{"key":"key20250711091203_B45"},{"issue":"(2):","key":"key20250711091203_B46","doi-asserted-by":"crossref","first-page":"255\u2013","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.","volume":"41","author":"Cosentino","year":"2020;","journal-title":"Eur Heart J"},{"issue":"(5):","key":"key20250711091203_B47","first-page":"657\u2013","article-title":"Towards better hypertension management in India.","volume":"139","author":"Gupta","year":"2014;","journal-title":"Indian J Med Res"},{"key":"key20250711091203_B48","doi-asserted-by":"crossref","first-page":"954757.","DOI":"10.4061\/2011\/954757","article-title":"Ambulatory blood pressure monitoring in diabetes and obesity\u2014a review.","volume":"2011:","author":"Eguchi","year":"2011;","journal-title":"Int J Hypertens"},{"issue":"(1):","key":"key20250711091203_B49","doi-asserted-by":"crossref","first-page":"87\u2013","DOI":"10.1038\/hr.2016.87","article-title":"Increased cardiovascular risk of treated white coat and masked hypertension in patients with diabetes and chronic kidney disease: the HONEST Study.","volume":"40","author":"Kushiro","year":"2017;","journal-title":"Hypertens Res"},{"issue":"(10159):","key":"key20250711091203_B50","first-page":"1736\u2013","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"392","year":"2018;","journal-title":"Lancet Lond Engl"},{"issue":"(3):","key":"key20250711091203_B51","doi-asserted-by":"crossref","first-page":"334\u2013","DOI":"10.1016\/j.diabres.2010.05.009","article-title":"The socioeconomics of diabetes from a developing country: a population based cost of illness study.","volume":"89","author":"Tharkar","year":"2010;","journal-title":"Diabetes Res Clin Pract"},{"issue":"(1):","key":"key20250711091203_B52","doi-asserted-by":"crossref","first-page":"103\u2013","DOI":"10.1016\/j.ecl.2013.09.005","article-title":"Type 2 diabetes mellitus and hypertension: an update.","volume":"43","author":"Lastra","year":"2014;","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"(11):","key":"key20250711091203_B53","doi-asserted-by":"crossref","first-page":"2668\u2013","DOI":"10.2337\/diacare.28.11.2668","article-title":"The association of comorbid depression with mortality in patients with type 2 diabetes.","volume":"28","author":"Katon","year":"2005;","journal-title":"Diabetes Care"},{"issue":"(7):","key":"key20250711091203_B54","doi-asserted-by":"crossref","first-page":"14\u2013","DOI":"10.5005\/japi-11001-0048","article-title":"The deadly duo of hypertension and diabetes in India: further affirmation from a new epidemiological study.","volume":"70","author":"G Metri","year":"2022;","journal-title":"J Assoc Physicians India"},{"issue":"(11):","key":"key20250711091203_B55","doi-asserted-by":"crossref","first-page":"199.","DOI":"10.21037\/atm.2018.04.36","article-title":"Blood pressure targets for hypertension in patients with type 2 diabetes.","volume":"6","author":"Aronow","year":"2018;","journal-title":"Ann Transl Med"},{"key":"key20250711091203_B56","doi-asserted-by":"crossref","first-page":"103758.","DOI":"10.1016\/j.amsu.2022.103758","article-title":"Prevalence of hypertension in type-2 diabetes mellitus.","volume":"78:","author":"Naseri","year":"2022;","journal-title":"Ann Med Surg."},{"issue":"(8):","key":"key20250711091203_B57","doi-asserted-by":"crossref","first-page":"588\u2013","DOI":"10.1038\/s41371-019-0212-0","article-title":"Blood pressure control in diabetes-the Indian perspective.","volume":"33","author":"Viswanathan","year":"2019;","journal-title":"J Hum Hypertens"},{"issue":"(1):","key":"key20250711091203_B58","doi-asserted-by":"crossref","first-page":"28\u2013","DOI":"10.3126\/ajms.v12i1.30508","article-title":"Association of hypertension and its risk factor in type II diabetes mellitus patients.","volume":"12","author":"Singh","year":"2021;","journal-title":"Asian J Med Sci"},{"issue":"(9733):","key":"key20250711091203_B59","first-page":"2215\u2013","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.","volume":"375","author":"Sarwar","year":"2010;","journal-title":"Lancet Lond Engl"},{"key":"key20250711091203_B60"},{"issue":"(11):","key":"key20250711091203_B61","doi-asserted-by":"crossref","first-page":"1185\u2013","DOI":"10.1038\/hr.2011.100","article-title":"Abnormalities in ambulatory blood pressure monitoring in hypertensive patients with diabetes.","volume":"34","author":"Gorostidi","year":"2011;","journal-title":"Hypertens Res"},{"key":"key20250711091203_B62","article-title":"Value of ambulatory blood pressure measurement in diagnosing hypotension in hypertensive diabetic patients with medication-controlled BP.","volume":"9:","author":"Alghalayini","year":"2020;","journal-title":"JRSM Cardiovasc Dis"},{"issue":"(3):","key":"key20250711091203_B63","doi-asserted-by":"crossref","first-page":"218\u2013","DOI":"10.2337\/ds17-0085","article-title":"Hypertension management in diabetes: 2018 update.","volume":"31","author":"Passarella","year":"2018;","journal-title":"Diabetes Spectr Publ Am Diabetes Assoc"},{"issue":"(8):","key":"key20250711091203_B64","doi-asserted-by":"crossref","first-page":"741\u2013","DOI":"10.1038\/hr.2014.66","article-title":"Is home blood pressure reporting in patients with type 2 diabetes reliable?","volume":"37","author":"Matsumoto","year":"2014;","journal-title":"Hypertens Res"},{"issue":"(7):","key":"key20250711091203_B65","first-page":"11\u2013","article-title":"Management of hypertension in patients with diabetes: a comprehensive review of the perceptions and practices of health care providers in India.","volume":"70","author":"S Ram","year":"2022;","journal-title":"J Assoc Physicians India"},{"issue":"(6):","key":"key20250711091203_B66","doi-asserted-by":"crossref","first-page":"431\u2013","DOI":"10.1046\/j.1464-5491.2001.00513.x","article-title":"Assessment of blood pressure in patients with type 2 diabetes: comparison between home blood pressure monitoring, clinic blood pressure measurement and 24-h ambulatory blood pressure monitoring.","volume":"18","author":"Masding","year":"2001;","journal-title":"Diabet Med"},{"issue":"(1):","key":"key20250711091203_B67","doi-asserted-by":"crossref","first-page":"51\u2013","DOI":"10.1161\/HYPERTENSIONAHA.111.188409","article-title":"Effect of home blood pressure telemonitoring with self-care support on uncontrolled systolic hypertension in diabetics.","volume":"60","author":"Logan","year":"2012;","journal-title":"Hypertension"},{"issue":"(8):","key":"key20250711091203_B68","doi-asserted-by":"crossref","first-page":"661\u2013","DOI":"10.1038\/hr.2013.38","article-title":"The reason why home blood pressure measurements are preferred over clinic or ambulatory blood pressure in Japan.","volume":"36","author":"Imai","year":"2013;","journal-title":"Hypertens Res"},{"key":"key20250711091203_B69","unstructured":"htn-draft-training-module_simple-version_05122019-for-print.pdf [Internet]. [cited 2023 May 25]. Available from: https:\/\/linkscommunity.org\/assets\/PDFs\/htn-draft-training-module_simple-version_05122019-for-print.pdf"},{"issue":"(3):","key":"key20250711091203_B70","first-page":"LC11\u2013","article-title":"Which is more accurate in measuring the blood pressure? A digital or an aneroid sphygmomanometer.","volume":"10","author":"Shahbabu","year":"2016;","journal-title":"J Clin Diagn Res"},{"key":"key20250711091203_B71","doi-asserted-by":"crossref","first-page":"3363.","DOI":"10.1038\/s41598-022-07315-z","article-title":"Diagnostic accuracy of mercurial versus digital blood pressure measurement devices: a systematic review and meta-analysis.","volume":"12:","author":"Muniyandi","year":"2022;","journal-title":"Sci Rep"},{"issue":"(3):","key":"key20250711091203_B72","first-page":"1464\u2013","article-title":"A comparative study of automated blood pressure device and mercury-free LED blood pressure device using Lin\u2019s concordance correlation coefficient and other validity measures in Indian population.","volume":"9","author":"Singh","year":"2020;","journal-title":"J Fam Med Prim Care"},{"issue":"(18):","key":"key20250711091203_B73","doi-asserted-by":"crossref","first-page":"1720\u2013","DOI":"10.1056\/NEJMoa1504347","article-title":"Excess mortality among persons with type 2 diabetes.","volume":"373","author":"Tancredi","year":"2015;","journal-title":"N Engl J Med"},{"issue":"(18):","key":"key20250711091203_B74","doi-asserted-by":"crossref","first-page":"1849\u2013","DOI":"10.1016\/j.jacc.2022.02.046","article-title":"Guidelines for cardiovascular risk reduction in patients with type 2 diabetes.","volume":"79","author":"Kelsey","year":"2022;","journal-title":"J Am Coll Cardiol"},{"issue":"(Suppl 2):","key":"key20250711091203_B75","first-page":"1\u2013","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for management of dyslipidemia and prevention of cardiovascular disease.","volume":"23","author":"Jellinger","year":"2017;","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"issue":"(29):","key":"key20250711091203_B76","doi-asserted-by":"crossref","first-page":"2315\u2013","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).","volume":"37","author":"Piepoli","year":"2016;","journal-title":"Eur Heart J"},{"issue":"(3):","key":"key20250711091203_B77","doi-asserted-by":"crossref","first-page":"178\u2013","DOI":"10.1016\/j.acvd.2010.11.013","article-title":"Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature.","volume":"104","author":"Valensi","year":"2011;","journal-title":"Arch Cardiovasc Dis"},{"issue":"(39):","key":"key20250711091203_B78","doi-asserted-by":"crossref","first-page":"4043\u2013","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.","volume":"44","author":"Marx","year":"2023;","journal-title":"Eur Heart J"},{"issue":"(10):","key":"key20250711091203_B79","doi-asserted-by":"crossref","first-page":"e2339098.","DOI":"10.1001\/jamanetworkopen.2023.39098","article-title":"Hypertension diagnosis, treatment, and control in India.","volume":"6","author":"Varghese","year":"2023;","journal-title":"JAMA Netw Open"},{"issue":"(9):","key":"key20250711091203_B80","doi-asserted-by":"crossref","first-page":"5738\u2013","DOI":"10.4103\/jfmpc.jfmpc_165_22","article-title":"Prevalence and determinants of isolated systolic and isolated diastolic hypertension in India: insights from the national family health survey (NFHS)-4.","volume":"11","author":"Gupta","year":"2022;","journal-title":"J Fam Med Prim Care"},{"issue":"(3):","key":"key20250711091203_B81","doi-asserted-by":"crossref","first-page":"272\u2013","DOI":"10.1016\/j.ihj.2019.07.007","article-title":"Isolated diastolic hypertension and its risk factors in semi-rural population of South India.","volume":"71","author":"Mittal","year":"2019;","journal-title":"Indian Heart J"},{"issue":"(9):","key":"key20250711091203_B82","doi-asserted-by":"crossref","first-page":"5792.","DOI":"10.4103\/jfmpc.jfmpc_163_22","article-title":"Tobacco use and uncontrolled hypertension among Indian men: insights from the National Family Health Survey (NFHS-4), 2015-2016.","volume":"11","author":"Singh","year":"2022;","journal-title":"J Fam Med Prim Care"},{"issue":"(3):","key":"key20250711091203_B83","doi-asserted-by":"crossref","first-page":"382\u2013","DOI":"10.1016\/j.ihj.2017.02.020","article-title":"Recent trends in epidemiology of dyslipidemias in India.","volume":"69","author":"Gupta","year":"2017;","journal-title":"Indian Heart J"},{"key":"key20250711091203_B84","doi-asserted-by":"crossref","first-page":"e649184.","DOI":"10.1155\/2015\/649184","article-title":"Prevalence and predictors of undiagnosed hypertension in an apparently healthy western Indian population.","volume":"2015:","author":"Shukla","year":"2015;","journal-title":"Adv Epidemiol"},{"key":"key20250711091203_B85","doi-asserted-by":"crossref","first-page":"2087064.","DOI":"10.1155\/2019\/2087064","article-title":"Heart rate in hypertension: review and expert opinion.","volume":"2019:","author":"Dalal","year":"2019;","journal-title":"Int J Hypertens"},{"issue":"(20):","key":"key20250711091203_B86","doi-asserted-by":"crossref","first-page":"3987.","DOI":"10.3390\/ijerph16203987","article-title":"The prevalence of overweight, obesity, hypertension, and diabetes in India: analysis of the 2015-2016 National Family Health Survey.","volume":"16","author":"Vennu","year":"2019;","journal-title":"Int J Environ Res Public Health"},{"key":"key20250711091203_B87","doi-asserted-by":"crossref","first-page":"1809\u2013","DOI":"10.2147\/DMSO.S363311","article-title":"Prevalence of hyperuricemia and the relationship between serum uric acid and hypertension in new onset diabetic patients: a cross-sectional Indian study.","volume":"15:","author":"Singh","year":"2022;","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"issue":"(2):","key":"key20250711091203_B88","doi-asserted-by":"crossref","first-page":"119\u2013","DOI":"10.1016\/j.gocm.2023.01.002","article-title":"Prevalence of hypertensive disorders of pregnancy, associated factors and pregnancy complications in a primigravida population.","volume":"3","author":"Mathew","year":"2023;","journal-title":"Gynecol Obstet Clin Med"},{"issue":"(1):","key":"key20250711091203_B89","doi-asserted-by":"crossref","first-page":"373\u2013","DOI":"10.1016\/j.dsx.2021.01.013","article-title":"Age at menopause in India: a systematic review.","volume":"15","author":"Prasad","year":"2021;","journal-title":"Diabetes Metab Syndr"},{"issue":"(4):","key":"key20250711091203_B90","doi-asserted-by":"crossref","first-page":"1289\u2013","DOI":"10.1161\/HYPERTENSIONAHA.120.15373","article-title":"Exposure to particulate matter is associated with elevated blood pressure and incident hypertension in urban India.","volume":"76","author":"Prabhakaran","year":"2020;","journal-title":"Hypertension"},{"issue":"(4):","key":"key20250711091203_B91","doi-asserted-by":"crossref","first-page":"155\u2013","DOI":"10.1515\/jtim-2015-0019","article-title":"Prevalence and impact of diabetes, hypertension, and cardiovascular diseases in chronic obstructive pulmonary diseases: a hospital-based cross-section study.","volume":"3","author":"Mahishale","year":"2015;","journal-title":"J Transl Intern Med"},{"key":"key20250711091203_B92","doi-asserted-by":"crossref","first-page":"1205475.","DOI":"10.3389\/fcvm.2023.1205475","article-title":"Hypertensive heart disease: risk factors, complications and mechanisms.","volume":"10:","author":"Masenga","year":"2023;","journal-title":"Front Cardiovasc Med"},{"issue":"(6):","key":"key20250711091203_B93","doi-asserted-by":"crossref","first-page":"1056\u2013","DOI":"10.1161\/01.HYP.0000167152.98618.4b","article-title":"Management of prehypertension.","volume":"45","author":"Svetkey","year":"2005;","journal-title":"Hypertension"},{"issue":"(1 Suppl):","key":"key20250711091203_B94","doi-asserted-by":"crossref","first-page":"93S\u2013","DOI":"10.1177\/1010539515616453","article-title":"Prevalence and correlates of prehypertension among adults in urban south India.","volume":"28","author":"Parthaje","year":"2016;","journal-title":"Asia-Pac J Public Health Asia-Pac Acad Consort Public Health"},{"issue":"(8):","key":"key20250711091203_B95","first-page":"1\u2013","article-title":"Prevalence of prehypertension and its correlation with Indian diabetic risk score in rural population.","volume":"6","author":"M","year":"2013;","journal-title":"Indian J Sci Technol"},{"issue":"(6):","key":"key20250711091203_B96","doi-asserted-by":"crossref","first-page":"1221\u2013","DOI":"10.1111\/jch.14246","article-title":"Diabetes modifies the association of prehypertension with cardiovascular disease and all-cause mortality.","volume":"23","author":"Ren","year":"2021;","journal-title":"J Clin Hypertens"},{"issue":"(8):","key":"key20250711091203_B97","doi-asserted-by":"crossref","first-page":"863\u2013","DOI":"10.1038\/ajh.2011.77","article-title":"Management of blood pressure in patients with diabetes.","volume":"24","author":"Grossman","year":"2011;","journal-title":"Am J Hypertens"},{"issue":"(4):","key":"key20250711091203_B98","doi-asserted-by":"crossref","first-page":"320\u2013","DOI":"10.1111\/1753-0407.12524","article-title":"American Diabetes Association Standards of Medical Care in Diabetes 2017.","volume":"9","author":"Marathe","year":"2017;","journal-title":"J Diabetes"},{"issue":"(2):","key":"key20250711091203_B99","doi-asserted-by":"crossref","first-page":"155\u2013","DOI":"10.1161\/01.HYP.38.2.155","article-title":"DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension.","volume":"38","author":"Moore","year":"2001;","journal-title":"Hypertension"},{"issue":"(3):","key":"key20250711091203_B100","doi-asserted-by":"crossref","first-page":"193\u2013","DOI":"10.2165\/00007256-200030030-00004","article-title":"The role of exercise training in the treatment of hypertension: an update.","volume":"30","author":"Hagberg","year":"2000;","journal-title":"Sports Med Auckl NZ"},{"issue":"(1):","key":"key20250711091203_B101","doi-asserted-by":"crossref","first-page":"1542.","DOI":"10.1186\/s12889-019-7842-6","article-title":"Interventions targeting hypertension and diabetes mellitus at community and primary healthcare level in low- and middle-income countries:a scoping review.","volume":"19","author":"Correia","year":"2019;","journal-title":"BMC Public Health"},{"issue":"(9328):","key":"key20250711091203_B102","doi-asserted-by":"crossref","first-page":"235.","DOI":"10.1016\/S0140-6736(02)09512-0","article-title":"WHO reassesses appropriate body-mass index for Asian populations.","volume":"360","author":"Choo","year":"2002;","journal-title":"Lancet"},{"key":"key20250711091203_B103","doi-asserted-by":"crossref","first-page":"4039364.","DOI":"10.1155\/2021\/4039364","article-title":"Effect of yoga on blood pressure in prehypertension: a systematic review and meta-analysis.","volume":"2021:","author":"Khandekar","year":"2021;","journal-title":"ScientificWorldJournal"},{"issue":"(3):","key":"key20250711091203_B104","first-page":"432\u2013","article-title":"Yoga as antihypertensive lifestyle therapy: a systematic review and meta-analysis.","volume":"94","author":"Wu","year":"2019;","journal-title":"Mayo Clin Proc"},{"issue":"(19):","key":"key20250711091203_B105","first-page":"e779\u2013","article-title":"Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association.","volume":"141","author":"Arnold","year":"2020;","journal-title":"Circulation"},{"issue":"(12):","key":"key20250711091203_B106","doi-asserted-by":"crossref","first-page":"6500.","DOI":"10.3390\/ijms23126500","article-title":"Hypertension and type 2 diabetes\u2014the novel treatment possibilities.","volume":"23","author":"Przezak","year":"2022;","journal-title":"Int J Mol Sci"},{"issue":"(6):","key":"key20250711091203_B107","doi-asserted-by":"crossref","first-page":"861\u2013","DOI":"10.1046\/j.1365-2125.1999.00093.x","article-title":"Angioedema due to ACE inhibitors: increased risk in patients of African origin.","volume":"48","author":"Gibbs","year":"1999;","journal-title":"Br J Clin Pharmacol"},{"issue":"(6):","key":"key20250711091203_B108","doi-asserted-by":"crossref","first-page":"319\u2013","DOI":"10.1038\/nrneph.2010.58","article-title":"The RAAS in the pathogenesis and treatment of diabetic nephropathy.","volume":"6","author":"Ruggenenti","year":"2010;","journal-title":"Nat Rev Nephrol"},{"issue":"(1):","key":"key20250711091203_B109","doi-asserted-by":"crossref","first-page":"505\u2013","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1-7)\/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7).","volume":"98","author":"Santos","year":"2018;","journal-title":"Physiol Rev"},{"key":"key20250711091203_B110","doi-asserted-by":"crossref","first-page":"34\u2013","DOI":"10.1016\/j.peptides.2014.07.002","article-title":"Angiotensin 1-7: a peptide for preventing and treating metabolic syndrome.","volume":"59:","author":"Santos","year":"2014;","journal-title":"Peptides"},{"issue":"(1):","key":"key20250711091203_B111","doi-asserted-by":"crossref","first-page":"F1\u2013","DOI":"10.1152\/ajprenal.00531.2013","article-title":"Renin-angiotensin system within the diabetic podocyte.","volume":"308","author":"M\u00e1rquez","year":"2015;","journal-title":"Am J Physiol-Ren Physiol"},{"issue":"(3):","key":"key20250711091203_B112","doi-asserted-by":"crossref","first-page":"591\u2013","DOI":"10.1161\/HYPERTENSIONAHA.120.16667","article-title":"Comparative first-line effectiveness and safety of ACE (Angiotensin-Converting Enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study.","volume":"78","author":"Chen","year":"2021;","journal-title":"Hypertension"},{"issue":"(2):","key":"key20250711091203_B113","doi-asserted-by":"crossref","first-page":"e0212907.","DOI":"10.1371\/journal.pone.0212907","article-title":"Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: systematic review and meta-analysis.","volume":"14","author":"Turgeon","year":"2019;","journal-title":"PLoS One"},{"issue":"(3):","key":"key20250711091203_B114","doi-asserted-by":"crossref","first-page":"768\u2013","DOI":"10.1159\/000489913","article-title":"Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality and renal outcomes in patients with diabetes and albuminuria: a systematic review and meta-analysis.","volume":"43","author":"Wang","year":"2018;","journal-title":"Kidney Blood Press Res"},{"key":"key20250711091203_B115","doi-asserted-by":"crossref","first-page":"f360.","DOI":"10.1136\/bmj.f360","article-title":"Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials.","volume":"346:","author":"Makani","year":"2013;","journal-title":"BMJ"},{"issue":"(15):","key":"key20250711091203_B116","first-page":"1547\u2013","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events.","volume":"358","author":"Yusuf","year":"2008;","journal-title":"N Engl J Med"},{"issue":"(12):","key":"key20250711091203_B117","doi-asserted-by":"crossref","first-page":"2890\u2013","DOI":"10.1681\/ASN.2018040443","article-title":"The long-term impact of renin-angiotensin system (RAS) inhibition on cardiorenal outcomes (LIRICO): a randomized, controlled trial.","volume":"29","author":"Saglimbene","year":"2018;","journal-title":"J Am Soc NephrolJASN"},{"issue":"(9):","key":"key20250711091203_B118","doi-asserted-by":"crossref","first-page":"1273\u2013","DOI":"10.2337\/dci17-0026","article-title":"Diabetes and hypertension: a position statement by the American Diabetes Association.","volume":"40","author":"de Boer","year":"2017;","journal-title":"Diabetes Care"},{"issue":"(6):","key":"key20250711091203_B119","doi-asserted-by":"crossref","first-page":"498\u2013","DOI":"10.1016\/S1262-3636(07)70147-7","article-title":"Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms.","volume":"30","author":"Scheen","year":"2004;","journal-title":"Diabetes Metab"},{"key":"key20250711091203_B120","doi-asserted-by":"crossref","first-page":"148.","DOI":"10.1186\/1471-2261-14-148","article-title":"Effects of ACEI\/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies.","volume":"14:","author":"Hao","year":"2014;","journal-title":"BMC Cardiovasc Disord"},{"issue":"(Suppl 2):","key":"key20250711091203_B121","first-page":"B35\u2013","article-title":"Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. the HOPE study investigators.","volume":"23","author":"Gerstein","year":"2000;","journal-title":"Diabetes Care"},{"key":"key20250711091203_B122","doi-asserted-by":"crossref","first-page":"5342161.","DOI":"10.1155\/2020\/5342161","article-title":"Comparison of effects of ACEIs and ARBs on albuminuria and hyperkalemia in Indonesian hypertensive type 2 diabetes mellitus patients.","volume":"2020:","author":"Agustina","year":"2020;","journal-title":"Int J Hypertens"},{"issue":"(1):","key":"key20250711091203_B123","doi-asserted-by":"crossref","first-page":"104\u2013","DOI":"10.1016\/j.amjmed.2020.05.039","article-title":"The effect of calcium channel blockers on moderate or severe albuminuria in diabetic, hypertensive patients.","volume":"134","author":"Cativo","year":"2021;","journal-title":"Am J Med"},{"key":"key20250711091203_B124","doi-asserted-by":"crossref","first-page":"3841\u2013","DOI":"10.2147\/DMSO.S310091","article-title":"Effect of angiotensin receptor blocker and angiotensin converting enzyme inhibitor on kidney function and blood potassium level in Indonesian type 2 diabetes mellitus with hypertension: a three-month cohort study.","volume":"14:","author":"Puspita","year":"2021;","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"issue":"(7):","key":"key20250711091203_B125","doi-asserted-by":"crossref","first-page":"e0253492.","DOI":"10.1371\/journal.pone.0253492","article-title":"Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers on insulin sensitivity in hypertensive patients: a meta-analysis of randomized controlled trials.","volume":"16","author":"Yao","year":"2021;","journal-title":"PLoS One"},{"issue":"(1):","key":"key20250711091203_B126","doi-asserted-by":"crossref","first-page":"37\u2013","DOI":"10.1038\/sj.jhh.1001931","article-title":"Meta-analysis of large outcome trials of angiotensin receptor blockers in hypertension.","volume":"20","author":"Cheung","year":"2006;","journal-title":"J Hum Hypertens"},{"issue":"(11):","key":"key20250711091203_B127","doi-asserted-by":"crossref","first-page":"950\u2013","DOI":"10.1038\/hr.2009.131","article-title":"Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy.","volume":"32","author":"Masuda","year":"2009;","journal-title":"Hypertens Res"},{"issue":"(3):","key":"key20250711091203_B128","doi-asserted-by":"crossref","first-page":"319\u2013","DOI":"10.1111\/j.1365-2710.2011.01295.x","article-title":"Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes.","volume":"37","author":"Suksomboon","year":"2012;","journal-title":"J Clin Pharm Ther"},{"issue":"(12):","key":"key20250711091203_B129","doi-asserted-by":"crossref","first-page":"1035\u2013","DOI":"10.1503\/cmaj.121771","article-title":"Comparative effectiveness of angiotensin-receptor blockers for preventing macrovascular disease in patients with diabetes: a population-based cohort study.","volume":"185","author":"Antoniou","year":"2013;","journal-title":"CMAJ"},{"issue":"(9638):","key":"key20250711091203_B130","doi-asserted-by":"crossref","first-page":"547\u2013","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.","volume":"372","author":"Mann","year":"2008;","journal-title":"Lancet"},{"issue":"(2):","key":"key20250711091203_B131","doi-asserted-by":"crossref","first-page":"250\u2013","DOI":"10.1161\/01.HYP.37.2.250","article-title":"Hypothesis: beta-adrenergic receptor blockers and weight gain: a systematic analysis.","volume":"37","author":"Sharma","year":"2001;","journal-title":"Hypertension"},{"issue":"(7 Suppl 1):","key":"key20250711091203_B132","doi-asserted-by":"crossref","first-page":"S21\u2013","DOI":"10.1016\/j.amjmed.2010.04.015","article-title":"The role of vasodilating beta-blockers in patients with hypertension and the cardiometabolic syndrome.","volume":"123","author":"Taylor","year":"2010;","journal-title":"Am J Med"},{"issue":"(8):","key":"key20250711091203_B133","first-page":"1254\u2013","article-title":"A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.","volume":"100","author":"Bangalore","year":"2007;","journal-title":"Am J Cardiol"},{"issue":"(1):","key":"key20250711091203_B134","doi-asserted-by":"crossref","first-page":"103\u2013","DOI":"10.1161\/HYPERTENSIONAHA.117.09259","article-title":"Risk of cardiovascular events in patients with diabetes mellitus on \u03b2-blockers.","volume":"70","author":"Tsujimoto","year":"2017;","journal-title":"Hypertension"},{"issue":"(25):","key":"key20250711091203_B135","doi-asserted-by":"crossref","first-page":"2091.","DOI":"10.1093\/eurheartj\/ehz125","article-title":"Concerning the degradation of b-blocker use in the 2018 ESC\/ESH hypertension guidelines.","volume":"40","author":"Morales-Salinas","year":"2019;","journal-title":"Eur Heart J"},{"issue":"(3):","key":"key20250711091203_B136","doi-asserted-by":"crossref","first-page":"378\u2013","DOI":"10.2174\/157016112799959323","article-title":"The effects of newer beta-adrenoceptor antagonists on vascular function in cardiovascular disease.","volume":"10","author":"Wehland","year":"2012;","journal-title":"Curr Vasc Pharmacol"},{"issue":"(3):","key":"key20250711091203_B137","doi-asserted-by":"crossref","first-page":"22.","DOI":"10.1007\/s11906-017-0716-3","article-title":"Differential metabolic effects of beta-blockers: an updated systematic review of nebivolol.","volume":"19","author":"Marketou","year":"2017;","journal-title":"Curr Hypertens Rep"},{"issue":"(1):","key":"key20250711091203_B138","doi-asserted-by":"crossref","first-page":"5\u2013","DOI":"10.1111\/bcpt.12396","article-title":"Third-generation beta-adrenoceptor antagonists in the treatment of hypertension and heart failure.","volume":"117","author":"Fisker","year":"2015;","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"(18):","key":"key20250711091203_B139","doi-asserted-by":"crossref","first-page":"2227\u2013","DOI":"10.1001\/jama.292.18.2227","article-title":"Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.","volume":"292","author":"Bakris","year":"2004;","journal-title":"JAMA"},{"key":"key20250711091203_B140","doi-asserted-by":"crossref","first-page":"1076107.","DOI":"10.3389\/fcell.2023.1076107","article-title":"Effects of \u03b2-blockers on all-cause mortality in patients with diabetes and coronary heart disease: a systematic review and meta-analysis.","volume":"11:","author":"Chen","year":"2023;","journal-title":"Front Cell Dev Biol"},{"issue":"(2):","key":"key20250711091203_B141","doi-asserted-by":"crossref","first-page":"311\u2013","DOI":"10.1016\/j.cld.2021.01.004","article-title":"Prevention of variceal bleeding and rebleeding by nonselective beta-blockers: a tailored approach.","volume":"25","author":"Jachs","year":"2021;","journal-title":"Clin Liver Dis"},{"issue":"(2):","key":"key20250711091203_B142","doi-asserted-by":"crossref","first-page":"103\u2013","DOI":"10.2174\/157340206776877370","article-title":"New generation calcium channel blockers in hypertensive treatment.","volume":"2","author":"Ozawa","year":"2006;","journal-title":"Curr Hypertens Rev"},{"issue":"(9):","key":"key20250711091203_B143","doi-asserted-by":"crossref","first-page":"677\u2013","DOI":"10.1056\/NEJM199903043400902","article-title":"Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.","volume":"340","author":"Tuomilehto","year":"1999;","journal-title":"N Engl J Med"},{"issue":"(4):","key":"key20250711091203_B144","doi-asserted-by":"crossref","first-page":"848\u2013","DOI":"10.2337\/db11-0955","article-title":"Preventing \u03b2-cell loss and diabetes with calcium channel blockers.","volume":"61","author":"Xu","year":"2012;","journal-title":"Diabetes"},{"key":"key20250711091203_B145","doi-asserted-by":"crossref","first-page":"257\u2013","DOI":"10.2147\/DMSO.S49767","article-title":"Effect of calcium channel blockers on incidence of diabetes: a meta-analysis.","volume":"6:","author":"Noto","year":"2013;","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"key20250711091203_B146","doi-asserted-by":"crossref","first-page":"935561.","DOI":"10.3389\/fendo.2022.935561","article-title":"Antihypertensive treatment improves glycemic control in patients with newly diagnosed type 2 diabetes mellitus: a prospective cohort study.","volume":"13:","author":"Li","year":"2022;","journal-title":"Front Endocrinol"},{"issue":"(Suppl 1):","key":"key20250711091203_B147","doi-asserted-by":"crossref","first-page":"S158\u2013","DOI":"10.2337\/dc23-S010","article-title":"10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023.","volume":"46","author":"ElSayed","year":"2023;","journal-title":"Diabetes Care."},{"issue":"(2):","key":"key20250711091203_B148","doi-asserted-by":"crossref","first-page":"e000473.","DOI":"10.1136\/openhrt-2016-000473","article-title":"Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes.","volume":"3","author":"Fares","year":"2016;","journal-title":"Open Heart"},{"issue":"(5):","key":"key20250711091203_B149","doi-asserted-by":"crossref","first-page":"322\u2013","DOI":"10.1097\/MJT.0000000000000202","article-title":"A systematic review on the efficacy of amlodipine in the treatment of patients with hypertension with concomitant diabetes mellitus and\/or renal dysfunction, when compared with other classes of antihypertensive medication.","volume":"22","author":"Jeffers","year":"2015;","journal-title":"Am J Ther"},{"issue":"(1):","key":"key20250711091203_B150","doi-asserted-by":"crossref","first-page":"38\u2013","DOI":"10.1038\/sj.jhh.1002100","article-title":"Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus.","volume":"21","author":"Nomura","year":"2007;","journal-title":"J Hum Hypertens"},{"issue":"(3):","key":"key20250711091203_B151","doi-asserted-by":"crossref","first-page":"431\u2013","DOI":"10.1161\/01.HYP.0000057420.27692.AD","article-title":"Outcomes with nifedipine GITS or co-amilozide in hypertensive diabetics and nondiabetics in intervention as a goal in hypertension (INSIGHT).","volume":"41","author":"Mancia","year":"2003;","journal-title":"Hypertension"},{"issue":"(1):","key":"key20250711091203_B152","doi-asserted-by":"crossref","first-page":"42\u2013","DOI":"10.1016\/0167-4889(85)90231-9","article-title":"Presence of a Ca2+-dependent K+ channel in brown adipocytes. Possible role in maintenance of alpha 1-adrenergic stimulation.","volume":"844","author":"N\u00e5nberg","year":"1985;","journal-title":"Biochim Biophys Acta"},{"issue":"(5):","key":"key20250711091203_B153","doi-asserted-by":"crossref","first-page":"1003\u2013","DOI":"10.1161\/01.HYP.0000215181.60228.f7","article-title":"Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis.","volume":"47","author":"Sugimoto","year":"2006;","journal-title":"Hypertension"},{"issue":"(3):","key":"key20250711091203_B154","doi-asserted-by":"crossref","first-page":"196\u2013","DOI":"10.1038\/hr.2012.141","article-title":"Cilnidipine regulates glucose metabolism and levels of high-molecular adiponectin in diet-induced obese mice.","volume":"36","author":"Ueno","year":"2013;","journal-title":"Hypertens Res"},{"issue":"(3):","key":"key20250711091203_B155","doi-asserted-by":"crossref","first-page":"504\u2013","DOI":"10.1016\/j.diabres.2014.09.056","article-title":"Effects of cilnidipine on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes mellitus: association with BNP and aldosterone levels.","volume":"106","author":"Tanaka","year":"2014;","journal-title":"Diabetes Res Clin Pract"},{"key":"key20250711091203_B156","doi-asserted-by":"crossref","first-page":"144\u2013","DOI":"10.22159\/ajpcr.2021.v14i1.39962","article-title":"Evaluation of renoprotective effect of cilnidipine in patients with mild to moderate hypertension and type 2 diabetes mellitus\u2014a prospective study.","author":"R","year":"2021;","journal-title":"Asian J Pharm Clin Res"},{"issue":"(9):","key":"key20250711091203_B157","doi-asserted-by":"crossref","first-page":"e12987.","DOI":"10.1111\/ijcp.12987","article-title":"Reduction in microalbuminuria by calcium channel blockers in patients with type 2 diabetes mellitus and hypertension\u2014a randomized, open-label, active-controlled, superiority, parallel-group clinical trial.","volume":"71","author":"Hwang","year":"2017;","journal-title":"Int J Clin Pract"},{"issue":"(8):","key":"key20250711091203_B158","first-page":"e27847.","article-title":"Renal function in hypertensive patients receiving cilnidipine and L-type calcium channel blockers: a meta-analysis of randomized controlled and retrospective studies.","volume":"14","author":"Srivathsan","year":"2022;","journal-title":"Cureus"},{"issue":"(1):","key":"key20250711091203_B159","doi-asserted-by":"crossref","first-page":"23\u2013","DOI":"10.1586\/14779072.2015.986464","article-title":"Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders.","volume":"13","author":"Shimada","year":"2015;","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"(5):","key":"key20250711091203_B160","doi-asserted-by":"crossref","first-page":"167\u2013","DOI":"10.14740\/cr494w","article-title":"Effects of cilnidipine on heart rate and uric acid metabolism in patients with essential hypertension.","volume":"7","author":"Das","year":"2016;","journal-title":"Cardiol Res"},{"issue":"(1):","key":"key20250711091203_B161","first-page":"47\u2013","article-title":"Excellent tolerance to cilnidipine in hypertensives with amlodipine-induced edema.","volume":"5","author":"Shetty","year":"2013;","journal-title":"North Am J Med Sci"},{"issue":"(6):","key":"key20250711091203_B162","doi-asserted-by":"crossref","first-page":"1143\u2013","DOI":"10.1097\/00004872-200206000-00026","article-title":"Effects of selective angiotensin II receptor blockade on sympathetic nerve activity in primary hypertensive subjects.","volume":"20","author":"Struck","year":"2002;","journal-title":"J Hypertens"},{"issue":"(6):","key":"key20250711091203_B163","doi-asserted-by":"crossref","first-page":"321\u2013","DOI":"10.1097\/MAJ.0b013e318065c254","article-title":"Azelnidipine reduces urinary protein excretion and urinary liver-type fatty acid binding protein in patients with hypertensive chronic kidney disease.","volume":"333","author":"Nakamura","year":"2007;","journal-title":"Am J Med Sci"},{"issue":"(11 Pt 1):","key":"key20250711091203_B164","doi-asserted-by":"crossref","first-page":"1083\u2013","DOI":"10.1016\/S0895-7061(01)02218-X","article-title":"The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study.","volume":"14","author":"Lefrandt","year":"2001;","journal-title":"Am J Hypertens"},{"issue":"(3):","key":"key20250711091203_B165","doi-asserted-by":"crossref","first-page":"168\u2013","DOI":"10.1111\/j.1524-6175.2007.05938.x","article-title":"Effects of valsartan or amlodipine alone or in combination on plasma catecholamine levels at rest and during standing in hypertensive patients.","volume":"9","author":"de Champlain","year":"2007;","journal-title":"J Clin Hypertens"},{"issue":"(2):","key":"key20250711091203_B166","doi-asserted-by":"crossref","first-page":"81\u2013","DOI":"10.4103\/2231-4040.154543","article-title":"Comparison of amlodipine with cilnidipine on antihypertensive efficacy and incidence of pedal edema in mild to moderate hypertensive individuals: a prospective study.","volume":"6","author":"Adake","year":"2015;","journal-title":"J Adv Pharm Technol Res"},{"issue":"(2):","key":"key20250711091203_B167","doi-asserted-by":"crossref","first-page":"124\u2013","DOI":"10.1111\/j.1755-5922.2009.00079.x","article-title":"Cilnidipine: a new generation Ca2+ channel blocker with inhibitory action on sympathetic neurotransmitter release.","volume":"27","author":"Takahara","year":"2009;","journal-title":"Cardiovasc Ther"},{"issue":"(5):","key":"key20250711091203_B168","doi-asserted-by":"crossref","first-page":"317\u2013","DOI":"10.1254\/fpj.113.317","article-title":"Effects of benidipine hydrochloride (Coniel) on blood pressure, heart rate and plasma norepinephrine concentration in spontaneously hypertensive rats.","volume":"113","author":"Karasawa","year":"1999;","journal-title":"Nihon Yakurigaku Zasshi"},{"issue":"(9):","key":"key20250711091203_B169","doi-asserted-by":"crossref","first-page":"2233\u2013","DOI":"10.18203\/2319-2003.ijbcp20173751","article-title":"Comparison of effects of benidipine and amlodipine on clinical and biochemical parameters in hypertensive patients: an observational study.","volume":"6","author":"Dange","year":"2017;","journal-title":"Int J Basic Clin Pharmacol"},{"issue":"(10):","key":"key20250711091203_B170","doi-asserted-by":"crossref","first-page":"767\u2013","DOI":"10.1291\/hypres.29.767","article-title":"Efficacy of azelnidipine on home blood pressure and pulse rate in patients with essential hypertension: comparison with amlodipine.","volume":"29","author":"Yamagishi","year":"2006;","journal-title":"Hypertens Res"},{"key":"key20250711091203_B171","first-page":"309\u2013","article-title":"Clinical use of azelnidipine in the treatment of hypertension in Chinese patients.","volume":"11:","author":"Chen","year":"2015;","journal-title":"Ther Clin Risk Manag"},{"issue":"(1):","key":"key20250711091203_B172","doi-asserted-by":"crossref","first-page":"83\u2013","DOI":"10.1080\/10641960802627363","article-title":"Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress.","volume":"31","author":"Morimoto","year":"2009;","journal-title":"Clin Exp Hypertens"},{"key":"key20250711091203_B173","first-page":"641\u2013","article-title":"Another therapeutic option to treat calcium channel blocker-related peripheral edema: can \u201cswitching to efonidipine hydrochloride\u201d be a new option?","volume":"53:","author":"Negishi","year":"2005;","journal-title":"Respir Circ"},{"key":"key20250711091203_B174","year":"2005.","journal-title":"J Clin Pharm Ther"},{"issue":"(4):","key":"key20250711091203_B175","first-page":"95\u2013","article-title":"Cilnidipine: next generation calcium channel blocker.","volume":"64","author":"Shete","year":"2016;","journal-title":"J Assoc Physicians India"},{"issue":"(8):","key":"key20250711091203_B176","doi-asserted-by":"crossref","first-page":"583\u2013","DOI":"10.1080\/10641960500298558","article-title":"Anti-proteinuric effect of an N-type calcium channel blocker, cilnidipine.","volume":"27","author":"Tsuchihashi","year":"2005;","journal-title":"Clin Exp Hypertens"},{"issue":"(6):","key":"key20250711091203_B177","doi-asserted-by":"crossref","first-page":"379\u2013","DOI":"10.1291\/hypres.27.379","article-title":"Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases.","volume":"27","author":"Kojima","year":"2004;","journal-title":"Hypertens Res"},{"issue":"(4):","key":"key20250711091203_B178","doi-asserted-by":"crossref","first-page":"429\u2013","DOI":"10.1291\/hypres.24.429","article-title":"Benidipine dilates both pre- and post-glomerular arteriole in the canine kidney.","volume":"24","author":"Yue","year":"2001;","journal-title":"Hypertens Res"},{"issue":"(4):","key":"key20250711091203_B179","doi-asserted-by":"crossref","first-page":"571\u2013","DOI":"10.1291\/hypres.25.571","article-title":"Effects of benidipine on glomerular hemodynamics and proteinuria in patients with nondiabetic nephropathy.","volume":"25","author":"Morikawa","year":"2002;","journal-title":"Hypertens Res"},{"issue":"(2):","key":"key20250711091203_B180","doi-asserted-by":"crossref","first-page":"268\u2013","DOI":"10.1038\/hr.2010.221","article-title":"Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria.","volume":"34","author":"Abe","year":"2011;","journal-title":"Hypertens Res"},{"issue":"(2):","key":"key20250711091203_B181","doi-asserted-by":"crossref","first-page":"202\u2013","DOI":"10.1111\/jdi.12003","article-title":"Comparison of effects of cilnidipine and azelnidipine on blood pressure, heart rate and albuminuria in type 2 diabetics with hypertension: a pilot study.","volume":"4","author":"Abe","year":"2013;","journal-title":"J Diabetes Investig"},{"issue":"(1):","key":"key20250711091203_B182","doi-asserted-by":"crossref","first-page":"81\u2013","DOI":"10.1111\/j.1527-3466.2002.tb00084.x","article-title":"Efonidipine hydrochloride: a dual blocker of L- and T-type Ca 2+ channels.","volume":"20","author":"Tanaka","year":"2002;","journal-title":"Cardiovasc Drug Rev"},{"issue":"(2):","key":"key20250711091203_B183","doi-asserted-by":"crossref","first-page":"448\u2013","DOI":"10.1016\/j.ijcard.2011.10.133","article-title":"A crossover comparison of urinary albumin excretion as a new surrogate marker for cardiovascular disease among 4 types of calcium channel blockers.","volume":"166","author":"Konoshita","year":"2013;","journal-title":"Int J Cardiol"},{"issue":"(5):","key":"key20250711091203_B184","doi-asserted-by":"crossref","first-page":"981\u2013","DOI":"10.1007\/s13300-017-0310-3","article-title":"A practical approach to hypertension management in diabetes.","volume":"8","author":"Shaikh","year":"2017;","journal-title":"Diabetes Ther"},{"issue":"(33):","key":"key20250711091203_B185","doi-asserted-by":"crossref","first-page":"3021\u2013","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension.","volume":"39","author":"Williams","year":"2018;","journal-title":"Eur Heart J"},{"issue":"(12):","key":"key20250711091203_B186","doi-asserted-by":"crossref","first-page":"1401\u2013","DOI":"10.1001\/archinte.165.12.1401","article-title":"Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).","volume":"165","author":"Whelton","year":"2005;","journal-title":"Arch Intern Med"},{"issue":"(3):","key":"key20250711091203_B187","doi-asserted-by":"crossref","first-page":"797\u2013","DOI":"10.1038\/s41440-022-01150-5","article-title":"Optimizing antihypertensive therapy in patients with diabetes mellitus.","volume":"46","author":"Liu","year":"2023;","journal-title":"Hypertens Res"},{"issue":"(4):","key":"key20250711091203_B188","doi-asserted-by":"crossref","first-page":"342\u2013","DOI":"10.1111\/jch.12679","article-title":"Association of thiazide-type diuretics with glycemic changes in hypertensive patients: a systematic review and meta-analysis of randomized controlled clinical trials.","volume":"18","author":"Zhang","year":"2016;","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"(23):","key":"key20250711091203_B189","doi-asserted-by":"crossref","first-page":"1886\u2013","DOI":"10.1001\/jama.1996.03540230036032","article-title":"Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.","volume":"276","author":"Curb","year":"1996;","journal-title":"JAMA"},{"issue":"(13):","key":"key20250711091203_B190","first-page":"2926\u2013","article-title":"Hydrochlorothiazide hypertension treatment induced metabolic effects in type 2 diabetes: a meta-analysis of parallel-design RCTs.","volume":"20","author":"Lin","year":"2016;","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"(4):","key":"key20250711091203_B191","doi-asserted-by":"crossref","first-page":"282\u2013","DOI":"10.1016\/j.jash.2016.02.008","article-title":"Is there a preferred diuretic class for patients with renal impairment and hypertension?","volume":"10","author":"Izzo","year":"2016;","journal-title":"J Am Soc Hypertens"},{"issue":"(5):","key":"key20250711091203_B192","doi-asserted-by":"crossref","first-page":"385\u2013","DOI":"10.1016\/S2213-8587(14)70030-0","article-title":"Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial.","volume":"2","author":"Kwakernaak","year":"2014;","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"(4):","key":"key20250711091203_B193","doi-asserted-by":"crossref","first-page":"839\u2013","DOI":"10.1161\/01.HYP.0000259805.18468.8c","article-title":"Effect of spironolactone on blood pressure in subjects with resistant hypertension.","volume":"49","author":"Chapman","year":"2007;","journal-title":"Hypertension"},{"issue":"(6):","key":"key20250711091203_B194","doi-asserted-by":"crossref","first-page":"310\u2013","DOI":"10.1038\/ncpneph0192","article-title":"Adding spironolactone to conventional antihypertensives reduces albuminuria in patients with diabetic nephropathy.","volume":"2","author":"Epstein","year":"2006;","journal-title":"Nat Clin Pract Nephrol"},{"issue":"(12):","key":"key20250711091203_B195","doi-asserted-by":"crossref","first-page":"2641\u2013","DOI":"10.1681\/ASN.2009070737","article-title":"Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.","volume":"20","author":"Mehdi","year":"2009;","journal-title":"J Am Soc Nephrol"},{"issue":"(6):","key":"key20250711091203_B196","doi-asserted-by":"crossref","first-page":"1098\u2013","DOI":"10.1007\/s10157-015-1106-2","article-title":"Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial.","volume":"19","author":"Kato","year":"2015;","journal-title":"Clin Exp Nephrol"},{"issue":"(3-4):","key":"key20250711091203_B197","first-page":"381\u2013","article-title":"Predictors of hyperkalemia risk after hypertension control with aldosterone blockade according to the presence or absence of chronic kidney disease.","volume":"128","author":"Gwoo","year":"2014;","journal-title":"Nephron Clin Pract"},{"issue":"(2):","key":"key20250711091203_B198","doi-asserted-by":"crossref","first-page":"81\u2013","DOI":"10.1038\/sj.jhh.1001511","article-title":"Better blood pressure control: how to combine drugs.","volume":"17","author":"Brown","year":"2003;","journal-title":"J Hum Hypertens"},{"key":"key20250711091203_B199","first-page":"29\u2013","article-title":"Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers.","volume":"7:","author":"Kawabata","year":"2015;","journal-title":"Clin Pharmacol Adv Appl"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T09:12:30Z","timestamp":1752225150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.japi.org\/article\/japi-72-8-e1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":199,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.59556\/japi.72.0620"],"URL":"https:\/\/doi.org\/10.59556\/japi.72.0620","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]}}}